Establishment Labs Holdings (ESTA) Non-Current Assets (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Non-Current Assets came in at $105.2 million in Q1 2026, up 3.48% year-on-year from $101.7 million in Q1 2025, and down 1.88% quarter-over-quarter from $107.2 million in Q4 2025.
Establishment Labs Holdings (ESTA) Non-Current Assets (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Non-Current Assets history runs 10 years deep, the most recent figure standing at $105.2 million for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 3.48% year-over-year to $105.2 million in Q1 2026; TTM through Mar 2026 was $412.2 million, a 2.0% increase from a year earlier, with the FY2025 full-year figure at $107.2 million, up 3.31% from the prior year.
- Non-Current Assets slipped to $105.2 million in Q1 2026 per ESTA's latest filing, from $107.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $107.2 million in Q4 2025 and bottomed at $31.5 million in Q1 2022.
- The 5-year median for Non-Current Assets is $98.1 million (2024), against an average of $83.6 million.
- Across the five-year window, Non-Current Assets jumped 132.91% in 2022 and retreated 0.44% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $61.2 million in 2022, then surged by 53.28% to $93.7 million in 2023, then increased by 10.73% to $103.8 million in 2024, then climbed by 3.31% to $107.2 million in 2025, then slipped by 1.88% to $105.2 million in 2026.
- Per Business Quant, the three latest ESTA Non-Current Assets figures stand at $105.2 million (Q1 2026), $107.2 million (Q4 2025), and $99.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 105.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.21 Mn |
| Dec 31, 2025 | 107.23 Mn |
| Sep 30, 2025 | 99.30 Mn |
| Jun 30, 2025 | 100.50 Mn |
| Mar 31, 2025 | 101.67 Mn |
| Dec 31, 2024 | 103.79 Mn |
| Sep 30, 2024 | 99.73 Mn |
| Jun 30, 2024 | 98.96 Mn |
| Mar 31, 2024 | 98.14 Mn |
| Dec 31, 2023 | 93.74 Mn |
| Sep 30, 2023 | 83.81 Mn |
| Jun 30, 2023 | 76.28 Mn |
| Mar 31, 2023 | 67.32 Mn |
| Dec 31, 2022 | 61.16 Mn |
| Sep 30, 2022 | 49.49 Mn |
| Jun 30, 2022 | 43.46 Mn |
| Mar 31, 2022 | 31.54 Mn |
| Dec 31, 2021 | 26.26 Mn |
| Sep 30, 2021 | 23.65 Mn |
| Jun 30, 2021 | 23.94 Mn |